Abstract | OBJECTIVE: To investigate the prognostic prediction of a new indicator, combined by tumor grade and Ki-67, in patients with resected pancreatic ductal adenocarcinoma (PDAC). METHODS: Data were retrospectively collected from consecutive patients who underwent primary resection of pancreas from December 2012 to December 2017. Tumor grade and Ki-67 were reviewed from routine pathological reports. G-Ki67 was classified as three categories as I (G1/2 and Ki-67 < 40%), II (G1/2 and Ki-67 ≥ 40%), and III(G3/4 and all Ki-67). RESULTS: Cox regression analyses revealed that tumor stage (II vs. I: hazard ratio (HR), 3.781; 95% confidence index (CI), 2.844-5.025; P < 0.001; III vs. I: HR, 7.476; 95% CI, 5.481-10.20; P < 0.001) and G-Ki67 (II vs. I: HR, 1.299; 95% CI, 1.038-1.624; P = 0.022; III vs. I: HR, 1.942; 95% CI, 1.477-2.554; P < 0.001) were independent prognostic factors in the developing cohort. The result was rectified in the validation cohort. In subgroups analysis, G-Ki67 (II vs. I: HR, 1.866 ; 95% CI, 1.045-3.334; P = 0.035; III vs. I: HR, 2.333 ; 95% CI, 1.156-4.705; P = 0.018) also had a high differentiation for survival prediction. CONCLUSION: Our findings indicate that three-categories of G-Ki67 in resectable PDAC according to the routine pathological descriptions provided additional prognostic information complementary to the TNM staging system.
|
Authors | Bo Li, Xiaoyi Yin, Xiuwen Ding, Guoxiao Zhang, Hui Jiang, Cuimin Chen, Shiwei Guo, Gang Jin |
Journal | BMC surgery
(BMC Surg)
Vol. 23
Issue 1
Pg. 370
(Dec 08 2023)
ISSN: 1471-2482 [Electronic] England |
PMID | 38066512
(Publication Type: Journal Article)
|
Copyright | © 2023. The Author(s). |
Chemical References |
|
Topics |
- Humans
- Ki-67 Antigen
- Retrospective Studies
- Pancreatic Neoplasms
(pathology)
- Carcinoma, Pancreatic Ductal
(surgery, pathology)
- Prognosis
- Adenocarcinoma
(surgery)
|